http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study.
Heumann, P. (First author)DKFZ* ; Rosas, J. C.DKFZ* ; Aguado-Barrera, M. E. ; Azria, D. ; Benner, A.DKFZ* ; Briers, E. ; Bultijnck, R. ; Choudhury, A. ; Gómez-Caamaño, A. ; Kaaks, R.DKFZ* ; Lambrecht, M. ; Rancati, T. ; Rosenstein, B. S. ; De Ruysscher, D. ; Schmidt, M.DKFZ* ; Singer, S. ; Sperk, E. ; Stobart, H. ; Vega, A. ; Veldeman, L. ; Ward, T. ; Webb, A. ; West, C. M. ; Chang-Claude, J.DKFZ* ; Talbot, C. J. ; Rattay, T. ; consortia, R. (Collaboration Author) ; Seibold, P.DKFZ* ; Ost, P. (Contributor) ; Lievens, Y. (Contributor) ; Deseyne, P. (Contributor) ; Duprez, F. (Contributor) ; Van Eijkeren, M. (Contributor) ; Elhamin, E. (Contributor) ; Fonteyne, V. (Contributor) ; Van Greveling, A. (Contributor) ; Mareel, M. (Contributor) ; Monten, C. (Contributor) ; De Neve, W. (Contributor) ; Paelinck, L. (Contributor) ; Post, G. (Contributor) ; Swimberghe, M. (Contributor) ; Vandecasteele, K. (Contributor) ; Vercauteren, T. (Contributor) ; Aerts, R. (Contributor) ; Arredouani, S. (Contributor) ; Defraene, G. (Contributor) ; Van Limbergen, E. (Contributor) ; Peeters, S. (Contributor) ; Weltens, C. (Contributor) ; Vanneste, B. (Contributor) ; Bourgier, C. (Contributor) ; Brengues, M. (Contributor) ; Draghici, R. (Contributor) ; Michalet, M. (Contributor) ; Farcy-Jacquet, M.-P. (Contributor) ; Bons, F. (Contributor) ; Blaschke, T. (Contributor) ; Weiß, C. (Contributor) ; Helmbold, I. (Contributor) ; Müller, A. (Contributor) ; Weißenberger, C. (Contributor) ; Stegmaier, P. (Contributor) ; Claßen, J. (Contributor) ; Giesche, U. (Contributor) ; Sautter-Bihl, M.-L. (Contributor) ; Neu, B. (Contributor) ; Schnabel, T. (Contributor) ; Ehmann, M. (Contributor) ; Gauter-Fleckenstein, B. (Contributor) ; Giordano, F. (Contributor) ; Herskind, C. (Contributor) ; Veldwijk, M. R. (Contributor) ; Schäfer, J. (Contributor) ; Avuzzi, B. (Contributor) ; Cicchetti, A. (Contributor) ; Pisani, F. (Contributor) ; Giandini, T. (Contributor) ; Franceschini, M. (Contributor) ; Sangalli, C. (Contributor) ; Morlino, S. (Contributor) ; Lozza, L. (Contributor) ; De Santis, M. C. (Contributor) ; Noris Chiorda, B. (Contributor) ; Valdagni, R. (Contributor) ; Pietro, G. (Contributor) ; Delmastro, E. (Contributor) ; Garibaldi, E. (Contributor) ; Altabas, M. (Contributor) ; Delgado, A. (Contributor) ; Docampo, N. (Contributor) ; Giraldo, A. (Contributor) ; Magriña, S. (Contributor) ; Maldonado, X. (Contributor) ; Mollà, M. (Contributor) ; Piqué-Leiva, B. (Contributor) ; Ramos, M. (Contributor) ; Reyes, V. M. (Contributor) ; Seoane, A. (Contributor) ; Gutierrez-Enríquez, S. (Contributor) ; Aguado-Flor, E. (Contributor) ; Fuentes-Rios, O. (Contributor) ; Crujeiras González, A. (Contributor) ; Rodríguez-Lage, B. (Contributor) ; Fernández-Tajes, J. (Contributor) ; Calvo-Crespo, P. (Contributor) ; Currás, M. M. (Contributor) ; Carballo-Castro, A. (Contributor) ; Peleteiro-Higuero, P. (Contributor) ; Taboada-Valladares, B. (Contributor) ; Fajardo-Paneque, I. (Contributor) ; Sosa-Fajardo, P. (Contributor) ; Torrado-Moya, L. (Contributor) ; Tubío-Abuín, M. A. (Contributor) ; Dominguez-Rios, I. (Contributor) ; Lobato-Busto, R. (Contributor) ; Dunning, A. M. (Contributor) ; Fachal, L. (Contributor) ; Harrop, V. (Contributor) ; Payne, D. (Contributor) ; Keni, M. (Contributor) ; Dobbelaere, H. (Contributor) ; Johnson, K. (Contributor) ; Lavers, S. (Contributor) ; Wright, S. (Contributor) ; Thiagarajan, S. (Contributor) ; Aznar-Garcia, L. (Contributor) ; Kancherla, K. (Contributor) ; Kent, C. (Contributor) ; Vasanthan, S. (Contributor) ; Bioangiu, I. (Contributor) ; Sampson, K. (Contributor) ; Osman, A. (Contributor) ; Appleton, D. (Contributor) ; Kaushik, M. (Contributor) ; Kenny, F. (Contributor) ; Khout, H. (Contributor) ; Krupa, J. (Contributor) ; Lambert, K. V. (Contributor) ; Pilgrim, S. (Contributor) ; Shokuhi, S. (Contributor) ; Valassiadou, K. (Contributor) ; Faivre-Finn, C. (Contributor) ; Foweraker, K. (Contributor) ; Pascoe, A. (Contributor) ; Esler, C. P. (Contributor) ; Elliott, R. M. (Contributor) ; Higginson, D. S. (Contributor) ; Green, S. (Contributor) ; Golchin, A. (Contributor) ; Stock, R. (Contributor) ; Kerns, S. L. (Contributor)
2026
Nature Publ. Group
Edinburgh
Abstract: Fatigue is a common symptom in cancer patients associated with impaired quality of life (QoL). Little is known about long-term fatigue trajectories in prostate cancer (PCa) patients.Using the European Organisation for Research and Treatment of Cancer Quality of Life Group Core Questionnaire (EORTC QLQ-C30), 1758 men treated with radiotherapy (2014-2016) for non-metastatic PCa prospectively reported fatigue up to five years later. Associations between pre-radiotherapy characteristics and clinically important fatigue (Score: ≥39/100) two years post-radiotherapy were investigated using logistic regression. Fatigue trajectories were explored using latent class growth analysis and multinomial regression.About 35% (608/1758) of patients experienced clinically important fatigue at least once from the start of radiotherapy up to five years later. Two years post-radiotherapy, 14% of patients reported fatigue, which was associated with pre-radiotherapy fatigue level (OR: 8.67), self-reported diabetes (OR: 1.94), BMI (OR: 1.07), and age (OR: 1.03). Long-term fatigue was strongly linked to pain, insomnia, pelvic symptoms, functional impairments, and reduced QoL. Four fatigue trajectories were identified, characterised by low (45%), moderate (42%), elevated and decreasing (8%), and (6%) increasing mean fatigue levels. Diabetes was associated with a 6 percentage point increase in the probability of experiencing an increasing fatigue trajectory.The findings emphasise the need for early identification of PCa patients susceptible to long-term fatigue. PCa patients with elevated pre-radiotherapy fatigue levels and diabetes may require closer monitoring in risk-stratified aftercare programmes.
Note: #EA:C020#LA:C020#LA:C130# / epub
Contributing Institute(s):
- Epidemiologie von Krebs (C020)
- Biostatistik (C060)
- Bewegung, Krebsprävention und Survivorship (C110)
- Personalisierte Früherkennung des Prostatakarzinoms (C130)
Research Program(s):
- 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)
Appears in the scientific report
2026
Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection